project id: TCGA-CESC; case submitter id: TCGA-FU-A3NI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 2.04; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.0; age at index: 45; days to birth: -16533; days to death: 638; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1965; age at diagnosis: 16533; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 44.0; figo stage: Stage IB1; icd 10 code: C53.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 466; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-FU-A3NI-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0;